Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Irinotecan hydrochloride 20 mg/ml concentrate for solution for infusion

Active Ingredient:
irinotecan hydrochloride trihydrate
Seacross Pharmaceuticals Ltd See contact details
ATC code: 
About Medicine
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
Last updated on emc: 31 Mar 2022
Seacross Pharmaceuticals Ltd
Company image
Stanmore Place, Honeypot Lane, Stanmore, London, HA7 1BT
+44 (0208 731 5273
+44 (0)203 727 0712
Medical Information Direct Line
+44 (0)208 731 5273
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0)208 731 5273
Medical Information Fax
+44 (0)203 727 0712